After President Trump’s first nominee to lead the Centers for Disease Control and Prevention (CDC) failed to gain traction ...

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...